Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Mar 23:10:1182206.
doi: 10.3389/fsurg.2023.1182206. eCollection 2023.

Editorial: New frontiers in pancreatic cancer care: Multidisciplinary approaches, the role of Pancreas Units, and their organizational impacts

Lorenzo Cobianchi  1   2   3 , Francesca Dal Mas  4 , Stefano Denicolai  3   5 , Pietro Previtali  3   5 , Alessandro Venturi  3   6   7
Affiliations
Editorial

Editorial: New frontiers in pancreatic cancer care: Multidisciplinary approaches, the role of Pancreas Units, and their organizational impacts

Lorenzo Cobianchi et al. Front Surg. .
No abstract available

Keywords: Pancreas Units; change management; clinical outcome; multidisciplinarity; organizational culture; pancreatic cancer; patient – centered care.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Frassini S, Calabretto F, Granieri S, Fugazzola P, Viganò J, Fazzini N, et al. Intraperitoneal chemotherapy in the management of pancreatic adenocarcinoma: a systematic review and meta-analysis. Eur J Surg Oncol. (2022) 48(9):1911–21. 10.1016/j.ejso.2022.05.030 - DOI - PubMed
    1. Barcellini A, Peloso A, Pugliese L, Vitolo V, Cobianchi L. Locally advanced pancreatic ductal adenocarcinoma: challenges and progress. Onco Targets Ther. (2020) 13:12705–20. 10.2147/OTT.S220971 - DOI - PMC - PubMed
    1. Hackert T, Sachsenmaier M, Hinz U, Schneider L, Michalski CW, Springfeld C, et al. Locally advanced pancreatic cancer: neoadjuvant therapy with folfirinox results in resectability in 60% of the patients. Ann Surg. (2016) 264(3):457–63. 10.1097/SLA.0000000000001850 - DOI - PubMed
    1. Vitolo V, Cobianchi L, Brugnatelli S, et al. Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm study. BMC Cancer. (2019) 19(922):1–7. 10.1186/s12885-019-6108-0 - DOI - PMC - PubMed
    1. Takahashi S, Ohno I, Ikeda M, Konishi M, Kobayashi T, Akimoto T, et al. Neoadjuvant S-1 with concurrent radiotherapy followed by surgery for borderline resectable pancreatic cancer: a phase II open-label multicenter prospective trial (JASPAC05). Ann Surg. (2022) 276(5):e510–e5. 10.1097/SLA.0000000000004535 - DOI - PubMed

Publication types

LinkOut - more resources